Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000842023-11-000015

Director sold 7,565 shares at an average $78.54 ($594,192)

  • Director acquired 7,565 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BAUMGARTNER ROBERT V · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2011-05-06 Exercise or conversion : show line 1 in the form +1,885 $32.90 $62,017 3,885 D
2011-05-06 Sale : show line 2 in the form −1,885 $78.68 $148,312 2,000 D
2011-05-09 Exercise or conversion : show line 3 in the form +680 $32.90 $22,372 2,680 D
2011-05-09 Exercise or conversion : show line 4 in the form +5,000 $37.10 $185,500 7,680 D
2011-05-09 Sale : show line 5 in the form −5,680 $78.50 $445,880 2,000 D
Open-market sales · 7,565 sh · avg $78.54 · $594,192

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2011-05-06 Exercise or conversion : show line 6 in the form Stock Option −1,885 $32.90 2013-10-23 2,565 680 D
2011-05-09 Exercise or conversion : show line 7 in the form Stock Option −680 $32.90 2013-10-23 680 0 D
2011-05-09 Exercise or conversion : show line 8 in the form Stock Option −5,000 $37.10 2014-10-20 5,000 0 D
Loading xslF345X03/primary_doc.xml…